|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 409/10 | |
| A61P 3/10 | |||
| A61P 27/02 | |||
| A61P 25/00 |
| (11) | Patento numeris | 3239149 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15871510.2 |
| Europos patento paraiškos padavimo data | 2015-03-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-11-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-01-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2015/075180 |
| Data | 2015-03-27 |
| (87) | Numeris | WO 2016/101432 |
| Data | 2016-06-30 |
| (30) | Numeris | Data | Šalis |
| 201410820560 | 2014-12-25 | CN |
| (72) |
WANG, Fei, CN
ZHANG, Jian, CN
LIN, Meng, CN
TANG, Yuanfu, CN
CHEN, Hao, CN
LEI, Huangshu, CN
|
| (73) |
Chongqing Pharmaceutical Industrial Research Institute Co. Ltd.,
No.565 Tushan Road Nan`an District, Chongqing 400061,
CN
|
| (54) | CRYSTAL FORM I OF CANAGLIFLOZIN AND PREPARATION METHOD THEREOF |
| CRYSTAL FORM I OF CANAGLIFLOZIN AND PREPARATION METHOD THEREOF |